Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Change in Inventory (2016)

Viridian Therapeutics, Inc.\DE has reported Change in Inventory over the past 3 years, most recently at $2000.0 for Q4 2016.

  • Quarterly results put Change in Inventory at $2000.0 for Q4 2016, up 101.13% from a year ago — trailing twelve months through Dec 2016 was -$123000.0 (down 1637.5% YoY), and the annual figure for FY2016 was -$123000.0, down 1637.5%.
  • Change in Inventory for Q4 2016 was $2000.0 at Viridian Therapeutics, Inc.\DE, up from -$151000.0 in the prior quarter.
  • Over the last five years, Change in Inventory for VRDN hit a ceiling of $206000.0 in Q2 2015 and a floor of -$232000.0 in Q1 2014.
  • Median Change in Inventory over the past 3 years was -$25500.0 (2014), compared with a mean of -$24416.7.
  • Peak annual rise in Change in Inventory hit 202.94% in 2015, while the deepest fall reached 541.03% in 2015.
  • Viridian Therapeutics, Inc.\DE's Change in Inventory stood at -$53000.0 in 2014, then tumbled by 233.96% to -$177000.0 in 2015, then surged by 101.13% to $2000.0 in 2016.
  • The last three reported values for Change in Inventory were $2000.0 (Q4 2016), -$151000.0 (Q3 2016), and -$56000.0 (Q2 2016) per Business Quant data.